Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin + vonoprazan dual regimen for Helicobacter pylori eradication (observational multicenter study)
ChiCTR2200059120Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vonoprazan in Helicobacter pylori infection (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Helicobacter pylori eradication rate. Planned start May 2022; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2200059120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059120.